参考文献 [1] Ibrahim SO, Vasstrand EN, Liavaag PG, et al. Expression of c-erbB proto-oncogene family members in squamous cell carcinoma of the head and neck. Anticancer Res, 1997,17(6D):4539-4546. [2] Wilkman TS, Hietanen JH, Malmstrom MJ, et al. Immunohistochemical analysis of the oncoprotein c-erbB-2 expression in oral benign and malignant lesions. Int J Oral Maxillofac Surg, 1998,27(3):209-212. [3] Milas L, Mason K, Hunter N, et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res, 2000,6(2):701-708. [4] Yarden Y. The EGFR family and its ligands in human cancer. signalling mechanisms and therapeutic opportunities. Eur J Cancer, 2001,37 Suppl 4:S3-S8. [5] Nagy P, Arndt-Jovin DJ, Jovin TM. Small interfering RNAs suppress the expression of endogenous and GFP-fused epidermal growth factor receptor (erbB1) and induce apoptosis in erbB1-overexpressing cells. Exp Cell Res, 2003,285(1):39-49. [6] Dai Q, Ling YH, Lia M, et al. Enhanced sensitivity to the HER1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib hydrochloride in chemotherapy-resistant tumor cell lines. Clin Cancer Res, 2005,11(4):1572-1578. [7] Harari PM, Huang SM. Head and neck cancer as a clinical model for molecular targeting of therapy: combining EGFR blockade with radiation. Int J Radiat Oncol Biol Phys, 2001,49(2):427-433. |